14.5 percent experience new-onset anxiety and 11.3 percent have new-onset depression in two years after implantation<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
FRIDAY, May 14, 2021 (HealthDay News) — New-onset anxiety and depression are common in the two years following the first-time placement of an implantable cardioverter defibrillator (ICD), according to a study presented at EHRA 2021, an online scientific congress hosted by the European Society of Cardiology.<\/p>\n
Susanne Pedersen, Ph.D., from the University of Southern Denmark in Odense, and colleagues used data from 1,040 patients with a first-time ICD implant (June 2010 to April 2013) without clinical levels of anxiety and depression at the time of implant. During 24 months of follow-up, the incidence of new-onset anxiety and depression was examined.<\/p>\n
The researchers found that the cumulative incidence of new-onset anxiety was 14.5 percent during follow-up, while the cumulative incidence of new-onset depression was 11.3 percent. There was an association observed between older age and a reduced risk for new-onset anxiety (hazard ratio [HR], 0.54), while being married (HR, 1.66), type D personality (HR, 2.50), and lower self-reported physical functioning (HR, 1.48) were associated with an increased risk for new-onset anxiety. For new-onset depression, older age (HR, 0.57) and higher self-reported physical functioning (HR, 0.46) were associated with a reduced risk, while smoking (HR, 2.13), type D personality (HR, 2.53), and lower self-reported physical functioning (HR, 1.64) were associated with an increased risk for new-onset depression.<\/p>\n
“Most patients adapt well to living with an ICD,” Pedersen said in a statement. “For others it completely changes their life, with worries about shocks from the device, body image, and livelihood.”<\/p>\n
Press Release<\/a><\/p>\n